Bone Marrow Mesenchymal Stem Cells in Acute-on-Chronic Liver Failure Grades 2 and 3: A Phase I-II Randomized Clinical Trial
Introduction. Acute-on-chronic liver failure (ACLF) is an acute liver decompensation in cirrhotic patients, which leads to organ failures and high short-term mortality. The treatment is based on the management of complications and, in severe cases, liver transplantation. Since specific treatment is...
Main Authors: | Fernando Comunello Schacher, Annelise Martins Pezzi da Silva, Lucia Mariano da Rocha Silla, Mario Reis Álvares-da-Silva |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2021-01-01
|
Series: | Canadian Journal of Gastroenterology and Hepatology |
Online Access: | http://dx.doi.org/10.1155/2021/3662776 |
Similar Items
-
The Role of Bone Marrow Mesenchymal Stem Cells in the Treatment of Acute Liver Failure
by: Shufang Yuan, et al.
Published: (2013-01-01) -
Effects of transplantation of human bone marrow mesenchymal stem cells in rats with liver failure
by: Yang-Gang Yan, et al.
Published: (2020-02-01) -
Mesenchymal Stem Cells in Immune-Mediated Bone Marrow Failure Syndromes
by: Maria-Christina Kastrinaki, et al.
Published: (2013-01-01) -
Bone marrow transplantation and acute myeloid leukemia: Brazilian guidelines
by: Lucia Mariano da Rocha Silla, et al.
Published: (2013-01-01) -
Overexpression of c-Met in bone marrow mesenchymal stem cells improves their effectiveness in homing and repair of acute liver failure
by: Kun Wang, et al.
Published: (2017-07-01)